Editorial: Personalising the Low FODMAP Diet to Achieve Therapeutic Benefit Whilst Reducing Burden and Maintaining Dietary Diversity in Irritable Bowel Syndrome. Authors' Reply

Ähnliche Einträge

• Editorial: Efficacy of Pharmacological Compared With Dietary Therapy for Patients With Irritable Bowel Syndrome—It Is Nice to Have a Choice. Authors' Reply
  von: Kee Huat Chuah, et al.
  Veröffentlicht: (2025)
• Editorial: Rebuilding Rome—Revising Diagnostic Criteria for Irritable Bowel Syndrome
  von: Mohsin F. Butt, et al.
  Veröffentlicht: (2024)
• Editorial: The Hidden Burden—Stigmatisation in Inflammatory Bowel Disease: Authors' Reply
  von: Suprabhat Giri, et al.
  Veröffentlicht: (2025)
• Stability of Classification Systems for Irritable Bowel Syndrome
  von: Mais Khasawneh, et al.
  Veröffentlicht: (2025)
• Editorial: New Insights Into the Aetiopathogenesis of Post‐Infective Irritable Bowel Syndrome and Functional Dyspepsia: A Significant Step Forward but What Next? Authors' Reply
  von: Mohamed H. Eldesouki, et al.
  Veröffentlicht: (2026)